Buradasınız

Anasayfa » Content

Progresif Oftalmopleji, Gastrointestinal ve Otonom Tutulumla Giden Mitokondriyal Miyopati Olgusu

Mitochondrial Myopathy Case with Progressive Ophtalmoplegia, Gastrointestinal and Autonomic Involvement

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2009

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Scientific Background: Mitochondrial myopathies can be hereditary or acquired and generally seen before 20 years old. Multisystem involvement, ophtalmoplegia, exercise intolerance are the most common symptoms. Can be found in Kearns-Sayre, MELAS, MERRF, NARP, MNGIE, CPEO subtypes. Objective: The case who could not be investigated genetically and who was diagnosed as mitocondrial myopathy after the biopsy; made us think about CPEO and MNGIE association with clinically findings like progressive ophtalmoplegia , gastrointestinal and autonomic involvements.The case is reported to emphasize the possibility of the coexistence of mitochondrial myopathy subgroups. Case: 33 years old male case examined with findings of hoarseness, cataract, exercise intolerance, progressive proximal muscle weakness, bilaterally ptosis, nasal voice, dysphagia, vomiting, diarrhea, vertigo and syncope. The case was consequent with mitochondrial myopathy with history and results of laboratory, electrophysiological, imaging techniques and biopsy. Conclusion: Biochemical analysis and tissue genetic analysis are necessary to determine subgroups of mitochondrial myopathies. Nevertheless, there are no certain treatment for mitochondrial myopathies currently.It is important to raise awareness of patients about this group of life threatening diseases and early diagnosis is importent.
Bookmark/Search this post with
Abstract (Original Language): 
Bilimsel Zemin: Mitokondrial miyopatiler kalıtımsal ya da edinsel olabilir ve genellikle 20 yaşından önce görülür. Multisistem tutulumu, oftalmopleji, egzersiz intoleransı en sık görülen bulgulardır. Kearns-Sayre, MELAS, MERRF, NARP, MNGIE, CPEO alt tiplerinde olabilir. Amaç: Genetik inceleme yapılamayan, biyopsi sonucu mitokondiriyal miyopati saptanan olgu, klinik olarak progresif eksternal oftalmopleji, gastrointestinal ve otonom bulgularıyla CPEO ve MNGIE birlikteliğini düşündürdü. Olgu, mitokondiriyal myopati alt gruplarının birlikte görülebilme olasılığını vurgulamak için sunuldu. Olgu: 33 yaşında erkek olgu, erken çocukluk döneminden itibaren ses kısıklığı, katarakt, egzersiz intoleransı, progresif proksimal kas güçsüzlüğü, bilateral pitoz, nazone konuşma, disfaji, kusma, diyare, vertigo, senkop yakınmalarıyla incelendi. Öykü, laboratuar, elektrofizyolojik inceleme, görüntüleme ve biyopsi sonuçlarıyla mitokondriyal miyopati ile uyumluydu. Yorum: Mitokondrial miyopatilerde, alt grupların belirlenmesi için biyokimyasal inceleme ve dokuda genetik inceleme gereklidir. Buna rağmen mitokondriyal miyopatilerde bugün için kesin tedavi bulunmamaktadır. Yaşamı tehdit eden bu grup hastalıklar hakkında, hastaların bilinçlendirilmesi yaşam planları açısından önemli olup erken tanı önemlidir.
FULL TEXT (PDF): 
PDF icon arastirmax-progresif-oftalmopleji-gastrointestinal-otonom-tutulumla-giden-mitokondriyal-miyopati-olgusu.pdf
  • 1
33-35
  • Turkish

REFERENCES

References: 

1. Kawai H, Akaike M, Yokoi K, Tamaki Y, Saito S. Mitochondrial myopathy with autosomal dominant inheritance-report of a family and review of the literature. Rinsho Shinkeigaku 1993;33(2):162-8.
2. Nonaka I. Mitochondrial diseases. Neurol Neurosurg 1992;5(5):622-32.
3. Vedanarayanan VV. Mitochondrial disorders and ataxia. Semin Pediatr Neurol 2003:10(3):200-9.
4. Ben Yaou R, Laforêt P. Misdiagnosis of mitochondrial myopathies: a study of 12 Thymectomized patients. Rev Neurol 2006; 162 (3): 339-46.
5. Mak SC, Chi CS, Chen CH, Shian WJ. Clinical manifestation of mitochondrial diseases in Children..Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1993;34(4):247-56.
6. Fadic R, Johns DR. Clinical spectrum of mitochondrial diseases.Sem Neurol 1996; 16:11-22.
7. Wolf NI, Smeitinik JAM. Mitochondrial disorders. Neurology 2002; 59: 1402-5.
8. Chakraborty PP, Mandal SK. Mitochondrial myopathy associated with myasthenia gravis in a young man. J Clin Neurosci 2007;14(7): 705-8.
9. Chinnery PF, Turnbull DM. Clinical features, investigation and management of patients with defects of mitochondrial DNA. J Neurol Neurosurg Psychiatry 1997; 63: 559-663.
10. Chu CC, Huang CC. Peripheral neuropathy in mitochondrial encephalomyopathies. Eur Neurol 1997;37(2):110-5.
11. Driscoll PF, Larsen PD, Gruber AB. MELAS syndrome involving a mother and two children. Arch Neurol 1987;44(9): 971-3.
12. Ciafaloni E, Ricci E, Shanske S. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992;31(4):391-8.
13. Kawai H, Akaike M, Yokoi K. Mitochondrial encephalomyopathy with autosomal dominant inheritance: a clinical and genetic entity of mitochondrial diseases. Muscle Nerve 1995;18 (7): 753-60.
14. Marie SK, Carvalho AA. Kearns-Sayre syndrome "plus". Classical clinical findings and dystonia. Arq Neuropsiquiatr 1999;57(4):1017-23.
15. Hirano M, Nishigaki Y. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. Neurologist 2004;10(1): 8-17.
16. Lee WT, Wang PJ, Cytochrome c oxidase deficiency in fibroblasts of a patient with mitochondrial encephalomyopathy.J Formos Med Assoc 1996; 95(9): 709-11.
17. Longo N, Schrijver I, Vogel H. Progressive cerebral vascular degeneration with mitochondrial encephalopathy; Am J Med Genet A 2008 1;146(3): 361-7.
18. Gillis L, Kaye E. Diagnosis and management of mitochondrial diseases. Pediatr Clin N Am 2002; 49: 203-19.

Thank you for copying data from http://www.arastirmax.com